With aging, multiple physiological changes occur in the connective tis
sue and vasculature of the nose which may predispose or contribute to
chronic rhinitis, Accurate differentiation of allergic from nonallergi
c causes of rhinitis requires skin testing or in vitro measures of spe
cific IgE. Empiric treatment with over-the-counter first generation an
tihistamines and oral decongestants frequently results in CNS, anticho
linergic and cardiovascular adverse effects. While newer second genera
tion histamine antagonists do not cause these problems, selected drugs
in this class may cause electrocardiographic QT prolongation and, in
rare cases, ventricular arrhythmias, Topical therapies including sodiu
m cromoglycate (cromolyn sodium), corticosteroids and ipratropium brom
ide are all well-tolerated with minimal adverse effects. Avoidance of
allergens and/or irritants is an important adjunct in treating patient
s with allergic and vasomotor rhinitis. If all other therapies fail in
patients with confirmed allergic rhinitis, immunotherapy can be safel
y instituted in most older patients.